Multicenter observational study on adherence and acceptance of lapatinib treatment in patients with HER2+ metastatic breast cancer.

Raffaele Addeo, S. Del Prete, Ferdinando Riccardi et al.|Journal of Clinical Oncology|2011

Cited by 2